Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome

AIMS: To assess the efficacy of a micronized-palmitoylethanolamide-polydatin (m-PEA-Pol) based product on chronic pelvic pain and severity of other symptoms in interstitial cystitis/bladder pain syndrome (IC/BPS) patients refractory to conventional therapies. METHODS: A pilot, open-label bicentric s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervigni, M., Nasta, L., Schievano, C., Lampropoulou, N., Ostardo, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885282/
https://www.ncbi.nlm.nih.gov/pubmed/31828153
http://dx.doi.org/10.1155/2019/9828397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885282/
https://www.ncbi.nlm.nih.gov/pubmed/31828153
http://dx.doi.org/10.1155/2019/9828397

Ejemplares similares